LifeMD Inc. (LFMDP)
Company Description
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States.
The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers.
It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents.
LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels.
The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021.
LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Country | United States |
IPO Date | Oct 5, 2021 |
Industry | Medical - Pharmaceuticals |
Sector | Healthcare |
Employees | 304 |
CEO | Justin Schreiber |
Contact Details
Address: 236 Fifth Avenue New York, New York United States | |
Website | https://www.lifemd.com |
Stock Details
Ticker Symbol | LFMDP |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000948320 |
CUSIP Number | 53216B203 |
ISIN Number | US53216B2034 |
Employer ID | 76-0238453 |
SIC Code | 8011 |
Key Executives
Name | Position |
---|---|
Justin Schreiber | Chairman & Chief Executive Officer |
Dennis Wijnker | Chief Technology Officer |
Eric H. Yecies | Chief Legal Officer, General Counsel & Corporate Secretary |
Jessica Friedeman | Chief Marketing Officer |
Marc Benathen | Chief Financial Officer |
James Porte | Senior Vice President of Patient Experience |
Maria E. Stan CPA | Chief Accounting Officer & Controller |
Nicholas P. Alvarez | Chief Acquisition Officer & Head of Customer Acquisition |
Shane Biffar | Chief Compliance Officer & Deputy General Counsel |
Stefan Galluppi | Chief Innovation Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 06, 2025 | 10-Q | Quarterly Report |
May 06, 2025 | 8-K | Current Report |
May 05, 2025 | 4 | Filing |
May 01, 2025 | 4 | Filing |
Apr 29, 2025 | 8-K | Current Report |
Apr 28, 2025 | ARS | Filing |
Apr 28, 2025 | DEFA14A | Filing |
Apr 28, 2025 | DEF 14A | Filing |
Apr 25, 2025 | 8-K | Current Report |
Apr 03, 2025 | 4 | Filing |